Udo F Legler

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. ncbi INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study
    Rhonda M Cooper-Dehoff
    University of Florida College of Pharmacy, Department of Pharmacotherapy and Translational Research, 1600 SW Archer Road, Box 100486, Gainesville, FL 32610 0486, USA
    Expert Rev Cardiovasc Ther 7:1329-40. 2009
  2. ncbi Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications
    Rhonda M Cooper-Dehoff
    Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, 1600 SW Archer Rd, Box 100486, Gainesville, FL 32610 0486, USA
    Hypertension 55:61-8. 2010
  3. ncbi Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease
    Rhonda M Cooper-Dehoff
    Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine, College of Pharmacy, University of Florida, 1600 SW Archer Rd, PO Box 100486, Gainesville, FL 32610 0486, USA
    JAMA 304:61-8. 2010
  4. ncbi Blood pressure lowering in patients with diabetes--one level might not fit all
    Rhonda M Cooper-Dehoff
    Department of Pharmacotherapy and Translational Research, College of Pharmacy, PO Box 100486, University of Florida, Gainesville, FL 32610 0486, USA
    Nat Rev Cardiol 8:42-9. 2011

Detail Information

Publications4

  1. ncbi INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study
    Rhonda M Cooper-Dehoff
    University of Florida College of Pharmacy, Department of Pharmacotherapy and Translational Research, 1600 SW Archer Road, Box 100486, Gainesville, FL 32610 0486, USA
    Expert Rev Cardiovasc Ther 7:1329-40. 2009
    ..g., risk for diabetes) and not necessarily that any one drug be given to all...
  2. ncbi Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications
    Rhonda M Cooper-Dehoff
    Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, 1600 SW Archer Rd, Box 100486, Gainesville, FL 32610 0486, USA
    Hypertension 55:61-8. 2010
    ..19 [95% CI: 1.35 to 7.52]). Development of adverse metabolic effect, including new-onset diabetes mellitus associated with short-term exposure to hydrochlorothiazide and atenolol was more common in those with abdominal obesity...
  3. ncbi Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease
    Rhonda M Cooper-Dehoff
    Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine, College of Pharmacy, University of Florida, 1600 SW Archer Rd, PO Box 100486, Gainesville, FL 32610 0486, USA
    JAMA 304:61-8. 2010
    ..Hypertension guidelines advocate treating systolic blood pressure (BP) to less than 130 mm Hg for patients with diabetes mellitus; however, data are lacking for the growing population who also have coronary artery disease (CAD)...
  4. ncbi Blood pressure lowering in patients with diabetes--one level might not fit all
    Rhonda M Cooper-Dehoff
    Department of Pharmacotherapy and Translational Research, College of Pharmacy, PO Box 100486, University of Florida, Gainesville, FL 32610 0486, USA
    Nat Rev Cardiol 8:42-9. 2011
    ..In the future, a personalized approach will maximize the benefits from treatment...